Patient with history of atrial fibrillation: 1 trials - ANTIPAF
olmesartan vs placebo | No demonstrated result |
All type of patients: 2 trials - ROADMAP - ORIENT
olmesartan vs placebo | No demonstrated result suggested Cardiovascular death by 312% (not demonstrated) |
All type of patients: 1 trials - ORIENT
olmesartan vs placebo | No demonstrated result |
All type of patients: 2 trials - ROADMAP - ORIENT
olmesartan vs placebo | No demonstrated result suggested Cardiovascular death by 312% (not demonstrated) |